Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mark

Showing results (611-620 of 623) with videos related to

Pageof 63
Sort By:
Archives of Sexual Behavior|February 11, 2026
Women Are Slightly More Sexually Satisfied in Their Romantic Relationships Than Men: An Integrative Data Analytic ApproachAshlyn Brady, Levi R Baker, Jessica A Maxwell, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Hepatobiliary cancers, version 2.2014Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 2, 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancersAl B Benson, Thomas A Abrams, Edgar Ben-Josef, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Pageof 63

Showing results (611-620 of 623) with videos related to

Sort By:
Pageof 63
Archives of Sexual Behavior|February 11, 2026
Women Are Slightly More Sexually Satisfied in Their Romantic Relationships Than Men: An Integrative Data Analytic ApproachAshlyn Brady, Levi R Baker, Jessica A Maxwell, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Hepatobiliary cancers, version 2.2014Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 2, 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancersAl B Benson, Thomas A Abrams, Edgar Ben-Josef, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Pageof 63